Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia

BACKGROUND: Heterogeneity among patients’ responses to treatment is prevalent in psychiatric disorders. Personalized medicine approaches—which involve parsing patients into subgroups better indicated for a particular treatment—could therefore improve patient outcomes and serve as a powerful tool in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellem, Monika S., Kollada, Matt, Tiller, Jane, Lauritzen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135147/
https://www.ncbi.nlm.nih.gov/pubmed/34016112
http://dx.doi.org/10.1186/s12911-021-01510-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135147/
https://www.ncbi.nlm.nih.gov/pubmed/34016112
http://dx.doi.org/10.1186/s12911-021-01510-0

Ejemplares similares